Seasonal allergic rhinitis management

Simpson, K., Jarvis, B., Fexofenadine a review of its use in the management of seasonal allergic rhinitis and chronic idiopathic urticaria, Drugs... 

Simpson K and Jarvis B (2000) Fexofenadine—a Review of Its Use in the Management of Seasonal Allergic Rhinitis and Chronic Idiopathic Urticaria. Drugs 59 pp 301-321. 

Murray JJ, Nathan RA, Bronsky EA, Olufade AO, Chapman D, Kramer B. Comprehensive evaluation of cetirizine in the management of seasonal allergic rhinitis impact on symptoms, quality of life, productivity, and activity impairment. Allergy Asthma Proc 2002 23(6) 391-8. 

Koyama, T., Kiijavainen, P. V., Fisher, C., Anukam, K., Summers, K., Hekmat, S., et al. (2010). Development and pilot evaluation of a novel probiotic mixture for the management of seasonal allergic rhinitis. Canadian Journal of Microbiology, 56(9), 730-738. 

Howarth, P., 1983, Astemizole in the management of seasonal allergic rhinitis, in Histamine and Allergic Disease (M. B. Emanuel, ed.), pp. 14-15, The Medicine Publishing Foundation, Oxford. 

Budesonide is a corticosteroid/flucocorticoid/intranasal steroid. It exhibits a wide range of inhibitory activities against multiple cell types and mediators involved in aller-gic-mediated inflammation. Its indications are Intranasal management of seasonal and perennial allergic rhinitis symptoms in adults and children oral inhalation for the maintenance treatment of asthma as prophylactic therapy in adults and children and for patients requiring oral corticosteroid therapy for asthma inhalation suspension maintenance treatment of asthma and prophylactic therapy in children 12 months to 8 years of age oral capsule Crohn s disease. 

Budesonide, an antiinflammatory corticosteroid (32 meg/ actuation and 256 meg/daily) is indicated in the management of seasonal or perennial allergic rhinitis in adults and children. 

Fluticasone is a corticosteroid that exerts potent antiinflammatory effect on nasal passages for management of the nasal symptoms of seasonal and perennial allergic and non-allergic rhinitis in adults and pediatric patients 4 years and older (Flonaze) patients requiring oral corticosteroid therapy for asthma (Flovent, Flovent Rotadisk, Flovent Dis-kus) maintenance treatment of asthma as prophylactic therapy in patients 4 years and older (Flovent Diskus, Flovent Rotadisk) and 12 years and older (Flovent). 

---